The PET packaging market in pharmaceuticals is witnessing robust growth, driven by rising demand for lightweight, durable, and sustainable packaging solutions. As the industry aims for sterility, safety, and cost-effectiveness, PET (Polyethylene Terephthalate) emerges as a game-changer—perfect for syrups, vitamin supplements, and liquid medications. With North America dominating the market in 2024 and Asia Pacific poised for rapid expansion, the global landscape is evolving at a significant pace.
North America held the largest revenue share at 38% in 2024, thanks to advanced healthcare systems and strong regulatory frameworks.
Asia Pacific is projected as the fastest-growing region between 2025 and 2034, fueled by increasing pharmaceutical production and demand for affordable packaging solutions.
By packaging type, PET Bottles led with a 60% revenue share in 2024, while blister packs are expected to register impressive CAGR growth.
In terms of drug forms, solid dosage forms accounted for 55% of revenue in 2024, but ophthalmic and nasal solutions are projected to grow rapidly in the coming years.
About: Amcor is a global leader in developing and producing responsible packaging solutions. With operations in over 40 countries, it emphasizes innovation and sustainability.
Products: PET bottles, blister packs, pharmaceutical pouches, and sterile medical packaging.
Market Cap: Approx. $15.2 billion (2025).
About: Gerresheimer AG, based in Germany, specializes in manufacturing pharmaceutical packaging and drug delivery devices.
Products: PET bottles, glass containers, prefillable syringes, and inhalers.
Market Cap: Approx. $4.3 billion (2025).
About: CCL Industries is a Canadian packaging giant and the world’s largest label company, serving healthcare, consumer goods, and specialty markets.
Products: Pharmaceutical labels, PET-based packaging, and security solutions.
Market Cap: Approx. $12.8 billion (2025).
About: Known for sustainable packaging innovations, Graham Packaging focuses on consumer and pharmaceutical markets with advanced PET designs.
Products: PET bottles, vials, and customized container solutions.
Market Cap: Privately held; estimated annual revenue ~$2.8 billion.
About: A diversified global packaging company, Sonoco provides consumer, industrial, healthcare, and protective packaging solutions.
Products: PET containers, healthcare packaging, and engineered materials.
Market Cap: Approx. $7.1 billion (2025).
About: A leading manufacturer of innovative delivery systems and components for injectable drugs.
Products: PET-based primary packaging, stoppers, seals, and prefilled syringe components.
Market Cap: Approx. $26.5 billion (2025).
About: Huhtamaki is a Finnish global leader in sustainable packaging solutions for food and pharmaceuticals.
Products: PET bottles, blister packs, and protective packaging solutions.
Market Cap: Approx. $4.6 billion (2025).
About: An emerging player in India’s pharmaceutical packaging industry, focusing on PET and HDPE solutions.
Products: PET bottles, tablet containers, and dropper bottles.
Market Cap: Privately held; estimated revenue ~$15 million.
About: AG Poly Packs is an Indian company specializing in high-quality plastic packaging for pharmaceuticals and personal care.
Products: PET containers, spray bottles, and customized designs.
Market Cap: Privately held; estimated revenue ~$10 million.
Invest in Our Premium Strategic Solution: https://www.towardspackaging.com/price/5696
About: Goldmine Polymers Industries caters to the pharmaceutical and cosmetic packaging market in India with a focus on PET innovations.
Products: PET bottles, jars, and pharma-grade packaging solutions.
Market Cap: Privately held; estimated revenue ~$8 million.
The PET packaging market in pharmaceuticals will continue to expand as manufacturers prioritize eco-friendly, lightweight, and tamper-evident solutions. Innovations in barrier technologies and recyclability will also play crucial roles in shaping market dynamics between 2025 and 2034.
Q1: Why is PET preferred for pharmaceutical packaging?
A: PET is lightweight, durable, offers excellent barrier properties, and ensures product sterility, making it ideal for pharmaceuticals.
Q2: Which region leads the PET packaging market?
A: North America held the largest share in 2024, while Asia Pacific is expected to grow fastest through 2034.
Q3: What drug forms are packaged in PET most commonly?
A: Solid dosage forms like tablets and capsules dominate, but liquid medications and ophthalmic solutions are growing segments.
Q4: What is the CAGR of the PET blister packs segment?
A: Blister packs are expected to register a significant CAGR between 2025 and 2034 due to demand for unit-dose packaging.
Q5: Who are the top global players in the PET pharmaceutical packaging market?
A: Key companies include Amcor, Gerresheimer, CCL Industries, Graham Packaging, and West Pharmaceutical Services.
Source : https://www.towardspackaging.com/insights/pet-packaging-in-pharmaceutical-market-sizing
The global packaging industry is undergoing a structural transformation, driven by environmental regulations, consumer awareness,…
The evolution of modern lifestyles has fundamentally reshaped packaging requirements across industries. As urban populations…
The functional packaging coatings market is undergoing a notable transformation as sustainability becomes a central…
The takeaway food packaging machinery market is entering a phase of accelerated transformation, driven by…
The global packaging industry is undergoing a structural shift toward sustainability, efficiency, and innovation. Within…
The dairy packaging market is entering a phase of steady transformation, driven by evolving consumer…